Male Breast Carcinoma — Trials

Male Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

104 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: H. Lee Moffitt Cancer Center and Research Institute
Termination share: 34%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (23)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03295695	PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient	withdrawn	Early Phase 1	0	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Dec 4, 2020	clinicaltrials
NCT01939483	A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases	withdrawn	N/A	0	University of California, IrvineOTHER	0	Oct 8, 2014	clinicaltrials